Congenital disorder of glycosylation type 2A
|
0.920 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Congenital disorder of glycosylation type 2A
|
0.920 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
MGAT2 deficiency (CDG-IIa): the Life of J.
|
19419693 |
2009 |
Congenital disorder of glycosylation type 2A
|
0.920 |
GeneticVariation
|
disease |
BEFREE |
However, crossing the Mgat2 mutation into a distinct genetic background resulted in a low frequency of survivors exhibiting additional and novel disease signs of CDG-IIa.
|
12417412 |
2002 |
Congenital disorder of glycosylation type 2A
|
0.920 |
Biomarker
|
disease |
MGD |
Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis.
|
11805078 |
2001 |
Congenital disorder of glycosylation type 2A
|
0.920 |
GeneticVariation
|
disease |
UNIPROT |
Congenital disorders of glycosylation IIa cause growth retardation, mental retardation, and facial dysmorphism.
|
11228641 |
2000 |
Congenital disorder of glycosylation type 2A
|
0.920 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development.
|
8808595 |
1996 |
Congenital disorder of glycosylation type 2A
|
0.920 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development.
|
8808595 |
1996 |
Congenital disorder of glycosylation type 2A
|
0.920 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development.
|
8808595 |
1996 |
Congenital disorder of glycosylation type 2A
|
0.920 |
Biomarker
|
disease |
CTD_human |
|
|
|
Congenital disorder of glycosylation type 2A
|
0.920 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Congenital disorder of glycosylation type 2A
|
0.920 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Spontaneous abortion
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
Abortion, Tubal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
Early Pregnancy Loss
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
Miscarriage
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
Aggressive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Diastema of Teeth
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Factor XII Deficiency
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Flatfoot
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congenital pectus excavatum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ventricular Septal Defects
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Macrostomia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|